FIELD: pharmacology.
SUBSTANCE: group of inventions refers to a complex compound of ferric iron or its pharmaceutically acceptable salt, containing at least one formula
ligand, drugs and compositions containing a complex compound of ferric iron.
EFFECT: implementation of the invention will provide a therapeutically active substance with good activity, a high degree of iron utilisation, stability and sufficient solubility.
16 cl, 4 tbl, 21 ex
Title | Year | Author | Number |
---|---|---|---|
COMPLEXES OF IRON (III) FOR TREATING AND PREVENTING IRON DEFICIENCY SYMPTOMS AND IRON DEFICIENCY ANAEMIA | 2011 |
|
RU2589710C2 |
SUBSTITUTED CYCLOHEXYLDIAMINES | 2009 |
|
RU2526251C2 |
NOVEL CYCLIN-DEPENDENT KINASE CDK9 INHIBITOR | 2018 |
|
RU2738654C1 |
METHOD OF MYOCARDIAL BLOOD PERFUSION IMAGING | 2012 |
|
RU2648358C2 |
SUBSTITUTED 4-AMINOCYCLOHEXANE DERIVATIVES | 2009 |
|
RU2503660C2 |
SUBSTITUTED DERIVATIVES OF 4-AMINOCYCLOHEXANE | 2009 |
|
RU2532545C2 |
ANTIBACTERIAL AGENT | 2000 |
|
RU2269525C2 |
PYRIDINESULFONAMIDE DERIVATIVES, PHARMACEUTICAL COMPOSITION BASED ON THE SAME AND USES THEREOF | 2002 |
|
RU2309148C2 |
SUBSTITUTED DERIVATIVES OF 4-AMINOCYCLOHEXANE | 2009 |
|
RU2525236C2 |
DERIVATIVES OF 6-AMINO QUINAZOLINE OR 3-CYANOQUINOLINE, METHODS OF THEIR PRODUCTION AND THEIR APPLICATION AS INHIBITORS OF RECEPTOR TYROZINE KINASES EGFR OR HER-2 | 2010 |
|
RU2536102C2 |
Authors
Dates
2018-01-15—Published
2013-12-19—Filed